Seeking Alpha
Profile| Send Message|
( followers)  

Jim Cramer, host of the television investment show “Mad Money,” issued “Buy” recommendations on these stocks on Aug. 3. I take a look at them today to see how they are performing.

Allergan Inc. (NYSE:AGN) – Founded in 1948, AGN develops and markets specialty pharmaceuticals and devices for a variety of medical specialty markets. Its market capitalization is $25.79 billion. It is currently trading around $84.55. It opened at $78.87 the morning after Cramer’s “Buy” recommendation, which was down from $79.79 the previous day. On Aug. 10, it reached a low of $70.36, and on Sept. 20 it reached a high of $84.30. Over the past 52 weeks it has fluctuation between a low of $64.95 and a high of $85.74. Its dividend yield is 0.2 percent, or $0.20 a share. It is showing a loss per share of $0.01. Price/earnings to growth is 1.53, and price to book value is 5.11. Return on equity is only 0.04 percent. Quarterly revenue growth is 13.6 percent, and quarterly earnings growth is 2.7 percent. AGN reports $2.61 billion in cash on hand and debt of $1.59 billion.

AGN’s mega-cap competitor Johnson& Johnson (NYSE:JNJ) is a 2011 Dividend Champion, having increased its payout 49 years in a row. Its dividend yield is 3.7 percent or $2.28. Earnings per share is 44.18, and price to earnings ratio is 15.27. Price/earnings to growth is 2.23, and price to book value is 2.77. Return on equity is 20.20 percent. Quarterly revenue growth is 8.3 percent. JNJ is showing a decline in quarterly earnings of 1.5 percent. It reports $29.68 billion in cash and $18.73 billion in debt. It is currently trading around $63.82.

Zack’s outlook for large-cap pharmaceutical stocks is “Neutral,” thanks to genericization and pricing pressure, though the investment research website notes that demand should be driven by emerging markets, government initiatives for healthcare, new patients, and greater use of generic drugs. Zack’s maintains a “Neutral” rating on AGN but notes that its presence across a variety of markets and geographies will help maintain growth over the coming months and years.

Though it is trading around its 52-week high, AGN appears to be positioned for growth. Industry outlook reaffirms this. I feel that the decision to buy this stock should be based on investors’ current levels of diversification and tolerance for risk.

Carrizo Oil & Gas Inc. (NASDAQ:CRZO) – This small-cap producer of oil and natural gas opened at $35.92 on Aug. 4, down from $36.54 at the previous day’s close. In the time since Cramer’s recommendation, CRZO reached a high of $33.38 on Aug. 4 and a low of $21.89 on Sept. 23. It is currently trading at $28.23. CRZO does not pay a dividend. It is showing a loss per share of $0.09. Price/earnings to growth is 0.51, and price to book value is 1.87. It is showing a negative return on equity of 0.75 percent. Quarterly revenue growth is 53.90 percent, and quarterly earnings growth is 333.70 percent. CRZO is carrying a lot of debt at $607 million. It reports cash of only $24.1 million. Its market capitalization is $936.45 million.

Abraxas Petroleum Corp. (NASDAQ:AXAS), another small-cap oil and natural gas company, is currently trading near $3.15. It does not pay a dividend. It is showing a loss per share of $0.19. Price/earnings to growth is not available. Price to book value is 6.04. Return on equity is -68.06 percent, quarterly revenue growth is 13.7 percent, and quarterly earnings growth is 68.6 percent. Its debt is also excessive at $97.65 million compared to its cash of $4.15 million. Its market capitalization is $288.25 million.

Some industry professionals see CRZO as creating value in excess of its cost of capital as measured by its “Economic Value Added” metric. CRZO enjoyed an 11.1 percent price jump yesterday. It reported record production for the second quarter of 2011, and company officials expect to meet production growth forecasts for the year.

Risk factors that could impact CRZO include lower oil and gas prices, common risks associated with drilling, risks specific to hydrofracking, competition and broader macro-economic conditions. CRZO has limited drilling experience in the Marcellus Shale, the Niobarra and the Eagle Ford Shale and its projected growth is reliant on the successful extraction of oil and gas from these areas. A substantial portion of CRZO’s reserves is located in an urban area. Because the success of its operations is contingent on hydrofracking, CRZO faces some very real environmental and regulatory risks.

CRZO is a risky investment. If Cramer is on the money with his “Buy” recommendation, then he will likely win big. Though I feel this stock is a gamble, it could pay off with large gains.

Darden Restaurants, Inc. (NYSE:DRI) – This operator of seafood and Italian chain restaurants has a market capitalization of $6.33 billion. It opened at $48.59 the morning after Cramer issued his “Buy” ranking. This was down from $49.28 the previous day. It fluctuated between a low of $43.37 on Sept 9 and a high of $48.53 on Aug. 16 in the period that followed the show. It is currently trading near $47, and its 52-week range is $42.37 to $53.81. Its dividend yield is 3.7 percent or $1.72 a share. DRI has paid a quarterly dividend since 2008 and a semi-annual dividend prior to that. Its payment history dates to 1995. Earnings per share is $3.39. Price to earnings ratio is 13.85, and price/earnings to growth is 0.91. Price to book value is 3.33. Return on equity is 25 percent. Quarterly revenue growth is 6.8 percent, and quarterly earnings growth is 18.9 percent. At $1.67 billion, DRI’s debt is high relative to its $74.1 million in cash.

Cramer issued a “Buy” on DRI’s competitor Chipotle Mexican Grill Inc. (NYSE:CMG) on Aug. 2. It is an expensive stock, trading around $320.60. Its price has fluctuated from $168.50 to $346.78 over the past 52 weeks. CMG’s price/earnings to growth ratio is 2.33, and its price to book value is 10.98. Return on equity is 22.7 percent. Quarterly revenue growth is 22.4 percent, and quarterly earnings growth is 9 percent. CMG carries $3.72 million in debt and $384.56 million in cash. CMG’s market capitalization is $10.95 billion.

DRI management attributes increased 2011 sales to having opened new restaurants throughout the year. Plans for 2012 include the opening of 80 to 90 new restaurants. Officials estimate total sales will increase 6 to 7 percent. Factors that could impact earnings include food inflation, recession and consumer spending patterns, among others. Analyst recommendation trends show strong buys and buys. Brand images of its restaurants like Red Lobster and Olive Garden are positive.

I like DRI’s dividend and support a “Buy” recommendation for investors seeking income-producing stocks. I also see its brands as popular and moderately priced, which could help maintain current outlooks under marginal macro economic conditions.

Devon Energy Corporation (NYSE:DVN) – This independent oil and natural gas producer with a market capitalization of $24.42 billion opened at $74.89 after Cramer’s “Buy” aired, which was almost a dollar down from $75.79 the previous day. In the weeks that followed, it ranged from a low of $55.37 on Sept. 23 to a high of $71.65 on Aug. 4. DVN is currently trading near $58.65. Its dividend yield is 1.2 percent or $0.68. Its payment history dates to 1993. Earnings per share is $13.60, and its price to earnings ratio is 4.31. Its price/earnings to growth ratio is 0,75, and price to book value is 1.12. Return on equity is 7.74 percent. Quarterly revenue growth is 28.20 percent, and quarterly earnings growth is spectacular at 288.50 percent. It is carrying $7.93 billion in debt and reports $6.8 billion in cash.

Its competitor Encana Corporation (NYSE:ECA) is currently trading near $20.65. Its dividend yield is 4 percent or $0.81 a share, and its payment history dates to 2002. ECA offers a dividend yield of 4 percent or $0.81 a share. Earnings per share is $0.98, and price to earnings is high at 21.07. Price/earnings to growth is 3.25, and price to book value is 0.88. Return on equity is 4.26 percent. Quarterly revenue growth is 35.2 percent, but quarterly earnings growth was not available. Debt is excessive at $8.49 billion relative to its cash of $870 million. Its market capitalization is $15.2 billion.

A weekly inventory report issued by The U.S. Energy Department showed natural gas inventories had built up, thanks to moderate fall temperatures and strong production. On Sept. 14, DVN announced a quarterly dividend of $0.17 a share payable to shareholders of record on Dec. 15. According to its most recent quarterly report for the period ended June 30, onshore oil and NGL production in North America increased 7 percent for the quarter and 5 percent for the first six months of the year. Gas production increased 4 percent for the quarter and 5 percent for the six months. Operating costs increased 3 percent for the quarter and the year, while operating cash flow increased 11 percent for the quarter and decreased 3 percent for the first half of the year. DVN’s production and earnings are subject to demand, environmental and conservation factors, weather, overall economic conditions, regulatory changes, particularly those specific to hydraulic fracking, and more.

Deutsche Bank initiated a “Hold” rating on DVN on Sept. 20. Another analyst issued an “Outperform” recommendation last March. Most current opinions are “Buys” and “Holds.”

Though it is poised for growth, DVN carries a lot of debt. It could prove to be a valuable investment in diversified portfolios, but it is still a gamble.

Herbalife Ltd. (NYSE:HLF) – This mid-cap network marketing company that sells weight management, energy, sports, and fitness products and nutritional supplements opened at $60.53 the morning after Cramer issued his “Buy” recommendation. This was down from $61.06 the previous day. In the weeks that followed, HLF ranged in price from a high of $57.98 at the end of the day on Aug. 4 to a low of $54.33 on Aug. 24. It is currently trading near $58.15. Its dividend yield is 1.5 percent or $0.80 a share. Its payment history dates to 2007. Earnings per share is $2.85, and HLF’s price to earnings ratio is 20.39. Price/earnings to growth is 1.2. Price to book value is 11.43. Return on equity is strong at 71.84 percent. Quarterly revenue growth, which is also strong, is 26.18 percent. We like HLF’s quarterly earnings growth of 35.3 percent, too. Cash of $254.47 million exceeds debt of $166.78 million. Market capitalization is $6.88 billion.

Its competitor GNC Holdings Inc. (NYSE:GNC) is currently trading around $21.70. It does not pay a dividend. Earnings per share is $1.02, and its price to earnings ratio is $21.33. Price/earnings to growth is 1.08. Price to book value is 2.51. Return on equity is 12.59 percent. Quarterly revenue growth is 13.8 percent, and quarterly earnings growth is 41. Percent. GNC reports cash of $97.97 million and debt of $902.21 million. Market capitalization is 2.27 billion.

Analysts remain optimistic about HLF, since consumers will still want supplements and weight management products in a weak economy. According to its most recent quarterly report, net sales increased 27.7 percent and 28.1 percent for the three and six months ended June 30, respectively, over the same periods last year. Gross profit increased 80.6 percent and 80.1 percent for the three and six months ended June 30, which was up over the same periods last year. Adverse global economic conditions could negatively impact HLF’s operating results as well as bad publicity about its products or ingredients. Competition is stiff. Expansion into new markets, specifically China, could pose political, regulatory and operational risks.

HLF is poised for growth. Its products are somewhat resistant to broader economic pressures. I feel it could be a very nice addition to investors’ holdings for a variety of reasons.

Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours.

Source: How 5 Cramer Picks From The August Rout Are Faring